Paragon 28’s (FNA) Hold Rating Reiterated at Needham & Company LLC

Needham & Company LLC reissued their hold rating on shares of Paragon 28 (NYSE:FNA) in a report issued on Wednesday, MarketBeat Ratings reports. Needham & Company LLC currently has a $13.00 price target on the stock.

Several other equities analysts have also weighed in on FNA. Stephens raised Paragon 28 to a “strong-buy” rating in a report on Monday, December 2nd. William Blair downgraded Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Finally, Canaccord Genuity Group lowered their price objective on Paragon 28 from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Paragon 28 presently has a consensus rating of “Hold” and an average target price of $14.60.

Paragon 28 Stock Down 0.0 %

Shares of NYSE:FNA opened at $13.03 on Wednesday. Paragon 28 has a 1 year low of $4.65 and a 1 year high of $14.79. The company has a market capitalization of $1.09 billion, a PE ratio of -17.60 and a beta of 1.50. The business has a fifty day moving average price of $10.59 and a two-hundred day moving average price of $8.42. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60.

Paragon 28 (NYSE:FNA) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.01. The business had revenue of $62.30 million during the quarter, compared to the consensus estimate of $60.58 million. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The firm’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the company posted ($0.10) earnings per share. Analysts forecast that Paragon 28 will post -0.64 earnings per share for the current year.

Insider Transactions at Paragon 28

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 27,142 shares of the firm’s stock in a transaction dated Monday, January 27th. The stock was sold at an average price of $11.62, for a total value of $315,390.04. Following the completion of the transaction, the insider now owns 10,313,841 shares in the company, valued at $119,846,832.42. This trade represents a 0.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 300,192 shares of company stock valued at $3,135,086 over the last three months. Company insiders own 15.32% of the company’s stock.

Institutional Investors Weigh In On Paragon 28

Several hedge funds and other institutional investors have recently modified their holdings of the stock. JPMorgan Chase & Co. grew its stake in Paragon 28 by 2,141.7% during the third quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock valued at $5,243,000 after acquiring an additional 749,865 shares in the last quarter. Millennium Management LLC grew its position in shares of Paragon 28 by 5,834.0% during the 2nd quarter. Millennium Management LLC now owns 725,489 shares of the company’s stock valued at $4,962,000 after purchasing an additional 713,263 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new position in shares of Paragon 28 during the 2nd quarter valued at $869,000. Stonepine Capital Management LLC bought a new position in shares of Paragon 28 in the third quarter worth $766,000. Finally, Sei Investments Co. purchased a new stake in shares of Paragon 28 in the second quarter worth $531,000. 63.57% of the stock is currently owned by institutional investors.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.